IPHOUM meeting
Nova Laboratories attended the IPHOUM meeting in Edinburgh in May 14, as part of Nova’s continued commitment to support treatment of children with acute lymphoblastic leukemia (ALL) through our licensed product, Xaluprine™, (Mercaptopurine oral suspension).
Downloads
Download all our latest product lists, this months Newsletter and news articles from Nova Laboratories.
Downloads
Career Opportunities
We welcome speculative enquiries and applications from anyone with experience in the pharmaceutical industry, the right attitude and relevant qualifications.
Know More